FLT3 and acute myeloid leukemia: On the other hand, the relapsed AML cells of the same patient after consolidation chemotherapy harbored clones including GATA2A372T (VAF, 26.1%), WT1D464G (VAF, 76.4%), and the 48-bp insertion of FLT3-ITD (VAF, 19.7%).